How should I manage a diabetic patient with acute Charcot foot?

Management of Acute Charcot Foot in Diabetic Patients

Immediately immobilize the affected foot in a non-removable knee-high device—preferably a total contact cast—as soon as you suspect Charcot foot, even before imaging confirmation, to prevent irreversible deformity and ulceration. 1, 2

Diagnosis and Initial Assessment

Clinical Recognition

• Always suspect active Charcot in any diabetic patient with peripheral neuropathy who presents with a unilaterally warm, swollen, erythematous foot with intact skin, even if pain is minimal or absent 1, 3, 2
• Measure skin temperature using infrared thermometry: a temperature difference ≥2°C between the affected and contralateral foot strongly suggests active Charcot disease 1, 2
• The ability to bear weight does not exclude Charcot—this is a critical pitfall that leads to delayed diagnosis and progressive deformity 2

Immediate Action Before Imaging

• Initiate knee-high immobilization/offloading immediately while diagnostic studies are being performed—do not wait for radiographic confirmation 1, 2
• The potential consequences of untreated Charcot (progressive deformity, ulceration, amputation) far outweigh the minimal risks of temporary immobilization in a patient who ultimately does not have Charcot 2

Imaging Protocol

• Obtain bilateral weight-bearing plain radiographs (anteroposterior, medial oblique, and lateral views of the foot; AP, mortise, and lateral views of the ankle) for comparison 1, 2
• If plain radiographs appear normal but clinical suspicion remains high, perform MRI to confirm or exclude active Charcot—this is a strong recommendation supported by moderate-quality evidence 1, 2
• If MRI is unavailable or contraindicated, consider bone scintigraphy, CT, or SPECT-CT as alternatives 1
• Do not order CRP, ESR, white blood count, or alkaline phosphatase for diagnosis—these blood tests do not help diagnose or exclude Charcot 1, 2

Treatment: Offloading Device Selection

Device Hierarchy (in order of preference)

First Choice: Total Contact Cast

• Provides optimal immobilization and pressure redistribution of the entire foot and ankle 1, 2
• This is the gold standard for treating active Charcot with intact skin 1, 3, 2

Second Choice: Knee-High Walker Rendered Non-Removable

• Achieve non-removability by encasing the walker with cast material or secure tie-wraps 1, 2
• Comparable efficacy to total contact cast when properly applied 2

Third Choice: Removable Knee-High Device

• Use only when non-removable devices are contraindicated or not tolerated 1, 2
• The main disadvantage is potential non-adherence, which markedly increases risk of disease progression 2
• Must confirm patient adherence because non-compliance compromises treatment 2

Devices to Avoid

• Never use below-ankle devices (surgical shoes, postoperative sandals, custom molded shoes, slipper casts)—they provide inadequate immobilization of the diseased midfoot and ankle joints and have limited offloading capacity 1, 2

Adjunctive Measures

• Prescribe assistive devices (crutches, walkers, or wheelchairs) to further reduce weight-bearing on the affected limb 1, 2
• Consider vitamin D and calcium supplementation during the fracture healing phase, in doses according to national guidelines for those at risk of vitamin D deficiency or insufficient calcium intake 1

Pharmacological Treatment: What NOT to Use

Do not use the following medications as they are not effective for treating active Charcot: 1, 3

• Bisphosphonates (alendronate, pamidronate, zoledronate)
• Calcitonin
• Parathyroid hormone (PTH)
• Methylprednisolone
• Denosumab

These agents have shown reduction in bone turnover markers but no significant clinical benefit in temperature reduction or disease resolution 1, 3

Monitoring for Disease Remission

Serial Assessment Parameters

• Conduct serial temperature measurements of both feet at each visit to track disease activity 1, 2
• Monitor clinical edema, but do not rely on soft tissue edema alone to determine remission 1
• Obtain follow-up imaging (radiographs and/or advanced imaging) to confirm bone healing and remodeling 2

Criteria for Remission

Continue immobilization until all three criteria are met: 2

1. Temperature difference normalizes to <2°C between feet
2. Clinical signs of inflammation (edema, erythema) resolve
3. Imaging demonstrates fracture healing and bone remodeling

The frequency of follow-up appointments should depend on fluctuation in edema volume, comorbidities, treatment risks, access to home care assistance, and the patient's progress 1

Surgical Intervention

Consider surgery in patients with: 1, 3

• Instability of foot and ankle joints
• Deformity with high risk of developing ulcers in the offloading device
• Pain that cannot be sufficiently stabilized in a total contact cast or non-removable knee-high device

Post-Remission Management to Prevent Reactivation

Footwear and Orthoses

• Provide customized footwear and/or orthoses that accommodate and support the shape of the foot and ankle to prevent reactivation 1, 3
• When deformity and/or joint instability is present, use below-knee customized devices for additional protection to optimize plantar pressure distribution 1, 3, 2

Critical Pitfalls to Avoid

• Delaying offloading until imaging confirmation—this leads to progressive deformity and ulceration 2
• Using inadequate immobilization with below-ankle devices—these fail to properly immobilize the affected joints 1, 2
• Relying on removable devices without confirming adherence—non-compliance permits disease progression 2
• Overlooking skin complications from improperly applied casts—monitor for new ulcers or blisters, which occur in approximately 14% of patients 2
• Failing to provide appropriate footwear after remission—this increases risk of reactivation 1, 3

Prognostic Considerations

Charcot foot significantly impacts quality of life and mortality, with a pooled 5-year mortality rate of 29% 3. Deformities increase the risk of ulceration and infection, leading to a 6-12 times increased risk of major amputation in individuals with foot ulcers resulting from Charcot deformity 3. Early recognition and aggressive immobilization are essential to prevent these devastating outcomes.